Novel humanized mesothelin-expressing genetically engineered mouse models underscore challenges in delivery of complex therapeutics to pancreatic cancers

Hagerty B
October 1, 2021
Mol Cancer Ther
https://pubmed.ncbi.nlm.nih.gov/34315768

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/34315768

Research summary

Key outcome of the study

Mouse model

TARGET:

Keywords

Technical specifications

Related products

Catalogue product

No items found.

Customized product

No items found.